Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,179 | 170 | 100.0% |
| Education | $1.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $514.51 | 10 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $394.02 | 26 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $282.56 | 16 | $0 (2024) |
| Amgen Inc. | $200.73 | 11 | $0 (2020) |
| PFIZER INC. | $183.40 | 11 | $0 (2024) |
| Tactile Systems Technology Inc | $177.54 | 12 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $161.54 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $156.81 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $138.26 | 7 | $0 (2018) |
| Gilead Sciences, Inc. | $108.00 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.79 | 11 | PFIZER INC. ($63.11) |
| 2023 | $237.38 | 11 | E.R. Squibb & Sons, L.L.C. ($74.66) |
| 2022 | $437.60 | 23 | Abbott Laboratories ($96.70) |
| 2021 | $159.65 | 10 | Janssen Pharmaceuticals, Inc ($68.70) |
| 2020 | $265.58 | 17 | Janssen Pharmaceuticals, Inc ($137.62) |
| 2019 | $508.94 | 31 | Novartis Pharmaceuticals Corporation ($109.02) |
| 2018 | $752.29 | 36 | Abbott Laboratories ($183.12) |
| 2017 | $594.17 | 32 | Abbott Laboratories ($140.29) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | CashFlow Solutions, LLC | LYMPHA PRESS OPTIMAL PLUS(US) BT (Device), PCD-51 731A (US) - White, PCD-52 737A (US) White | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Pneumatic Compressor | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/15/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Medical Device | ||||||
| 08/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/23/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Medical Device | ||||||
| 04/17/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Medical Device | ||||||
| 03/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/23/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Urology Gynecology | ||||||
| 01/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/01/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Urology Gynecology | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2023 | Siemens Medical Solutions USA, Inc. | Biograph Horizon-3R (Device) | Food and Beverage | In-kind items and services | $32.04 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/21/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/18/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/25/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.62 | General |
| Category: Cardiovascular | ||||||
| 05/05/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.71 | General |
| Category: Cardiovascular | ||||||
| 04/04/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Cardiovascular | ||||||
| 03/28/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 02/14/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/27/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/14/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/20/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 853 | 1,179 | $304,275 | $72,057 |
| 2022 | 19 | 1,079 | 1,566 | $434,331 | $108,336 |
| 2021 | 22 | 1,250 | 1,648 | $500,813 | $124,649 |
| 2020 | 27 | 1,567 | 2,588 | $645,516 | $150,433 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 289 | $63,402 | $18,095 | 28.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 32 | 32 | $46,400 | $11,237 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 76 | 76 | $47,915 | $11,221 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 70 | $22,890 | $6,204 | 27.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 35 | 140 | $25,900 | $6,016 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $19,428 | $4,132 | 21.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 59 | 64 | $13,760 | $3,404 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 242 | 323 | $14,535 | $3,246 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $10,890 | $2,746 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 17 | $10,455 | $2,320 | 22.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 32 | 64 | $21,440 | $1,803 | 8.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 33 | 33 | $7,260 | $1,632 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 216 | 313 | $77,145 | $21,479 | 27.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 116 | 119 | $74,939 | $19,073 | 25.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 45 | 46 | $65,437 | $16,655 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 84 | $30,156 | $8,429 | 28.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 42 | 169 | $30,992 | $8,009 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $20,907 | $5,019 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 266 | 375 | $16,753 | $4,024 | 24.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 14 | 14 | $12,972 | $3,233 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 52 | 52 | $11,302 | $2,919 | 25.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 14 | 14 | $10,914 | $2,831 | 25.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 41 | 64 | $28,060 | $2,657 | 9.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 45 | 46 | $10,102 | $2,324 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 39 | $8,497 | $2,232 | 26.3% |
About Dr. Imran Afridi, M.D
Dr. Imran Afridi, M.D is a Cardiovascular Disease healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861459927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Afridi, M.D has received a total of $3,180 in payments from pharmaceutical and medical device companies, with $224.79 received in 2024. These payments were reported across 171 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,179).
As a Medicare-enrolled provider, Afridi has provided services to 4,749 Medicare beneficiaries, totaling 6,981 services with total Medicare billing of $455,475. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Duncanville, TX
- Active Since 05/01/2006
- Last Updated 10/15/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861459927
Products in Payments
- XARELTO (Drug) $394.02
- ENTRESTO (Drug) $259.65
- ELIQUIS (Drug) $248.41
- Quadra Assura CRT Defibrillator (Device) $211.02
- Corlanor (Drug) $161.95
- LifeVest (Device) $161.54
- CRT-Ds (Device) $140.29
- Flexitouch Plus (Device) $126.44
- Letairis (Drug) $97.11
- CONFIRM RX (Device) $96.70
- LEXISCAN (Drug) $77.96
- PRALUENT ALIROCUMAB INJECTION (Biological) $75.58
- CAMZYOS (Drug) $74.66
- ClosureFast (Device) $61.00
- Lexiscan (Drug) $60.30
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $51.62
- FLEXITOUCH (Device) $51.10
- iTIND System (Device) $48.76
- PRADAXA (Drug) $46.58
- Repatha (Biological) $38.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.